Paper Details 
Original Abstract of the Article :
PURPOSE: To assess the efficacy, safety and tolerability of eslicarbazepine acetate (ESL) in patients transitioning from carbamazepine or oxcarbazepine to ESL in clinical practice, by analysing data from the Euro-Esli study. METHODS: Euro-Esli was a pooled analysis of 14 European clinical practice ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.seizure.2019.12.022

データ提供:米国国立医学図書館(NLM)

A Smooth Transition: Navigating the Shifting Sands of Epilepsy Treatment

The treatment of [illness] is a dynamic field with a constant evolution of therapies. This research examines the efficacy and safety of transitioning patients from [specific medications] to [specific medication] in clinical practice. The study utilizes data from [research methodology] to assess the effectiveness, side effects, and tolerability of [specific medication] in patients switching from previously prescribed medications.

Easing the Burden: Finding Stability in the Storm

The results indicate that [specific medication] appears to be a viable and well-tolerated option for patients who require a change in treatment. The study found that [percentage] of patients transitioning from [specific medication] to [specific medication] experienced [specific outcome]. These findings suggest that the transition to [specific medication] can be successful in achieving [specific goal] while minimizing potential risks.

Building Bridges for a Smoother Journey

This research emphasizes the need for careful consideration of individual patient needs and potential side effects when making treatment decisions. The study underscores the importance of open communication between patients and healthcare providers to ensure a smooth transition between medications and optimize treatment outcomes.

Dr.Camel's Conclusion

In the vast and often unpredictable landscape of epilepsy treatment, finding the right medication and managing potential side effects can feel like navigating a treacherous desert. This study offers a beacon of hope for patients seeking a smoother path to seizure control. By understanding the efficacy and tolerability of various medications, we can work together to ensure that patients receive the best possible care and experience the least amount of disruption along their journey.

Date :
  1. Date Completed 2020-11-13
  2. Date Revised 2020-11-13
Further Info :

Pubmed ID

31981862

DOI: Digital Object Identifier

10.1016/j.seizure.2019.12.022

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.